Publications
Selected publications
- A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial. (Journal article - 2022)
- Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials (Journal article - 2017)
- A Robust Parameterization for Unbounded Covariates Within the Cox Proportional Hazards Model (Journal article - 2014)
- Kernel hazard estimation for visualisation of the effect of a continuous covariates on time-to-event endpoints (Journal article - 2022)
2024
Diagnosis and management of selective fetal growth restriction in monochorionic twin pregnancies: A cross-sectional international survey.
Prasad, S., Khalil, A., Kirkham, J. J., Sharp, A., Woolfall, K., Mitchell, T. K., . . . FERN Study Team. (2024). Diagnosis and management of selective fetal growth restriction in monochorionic twin pregnancies: A cross-sectional international survey.. BJOG : an international journal of obstetrics and gynaecology, 131(12), 1684-1693. doi:10.1111/1471-0528.17891
Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial.
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L. C., . . . STRIDER group. (2024). Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial.. BJOG : an international journal of obstetrics and gynaecology, 131(12), 1673-1683. doi:10.1111/1471-0528.17888
Infliximab versus interferon-alpha in the treatment of Behçet's Syndrome: Clinical data from the BIO-BEHÇET'S randomised controlled trial.
Moots, R. J., Fortune, F., Jackson, R., Thornburn, T., Morgan, A., Carr, D. F., . . . Situnayake, D. (2024). Infliximab versus interferon-alpha in the treatment of Behçet's Syndrome: Clinical data from the BIO-BEHÇET'S randomised controlled trial.. Rheumatology (Oxford, England), keae585. doi:10.1093/rheumatology/keae585
Infliximab versus alpha interferon in the treatment of Behçet’s disease: the BIO BEHÇET’S RCT
Moots, R. J., Fortune, F., Jackson, R., Thornburn, T., Morgan, A. W., Carr, D., . . . Situnayake, D. (n.d.). Infliximab versus alpha interferon in the treatment of Behçet’s disease: the BIO BEHÇET’S RCT. Efficacy and Mechanism Evaluation, 1-77. doi:10.3310/htfc6304
The efficacy of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction: the STRIDER RCT
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (n.d.). The efficacy of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction: the STRIDER RCT. Efficacy and Mechanism Evaluation, 1-61. doi:10.3310/wakv3677
Longitudinal Dietary Intake Data in Patients with Phenylketonuria from Europe: The Impact of Age and Phenylketonuria Severity.
Pinto, A., Ahring, K., Almeida, M. F., Ashmore, C., Bélanger-Quintana, A., Burlina, A., . . . MacDonald, A. (2024). Longitudinal Dietary Intake Data in Patients with Phenylketonuria from Europe: The Impact of Age and Phenylketonuria Severity.. Nutrients, 16(17), 2909. doi:10.3390/nu16172909
Correction to: short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.
Weinstein, D. A., Jackson, R. J., Brennan, E. A., Williams, M., Davison, J. E., de Boer, F., . . . Mundy, H. R. (2024). Correction to: short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.. Orphanet journal of rare diseases, 19(1), 317. doi:10.1186/s13023-024-03305-8
Breast cancer research gaps: a questionnaire-based study to determine overall priorities and compare the priorities of patients, the public, clinicians and scientists.
Wilson, R. L., Boundouki, G., Jackson, R. J., Dave, R. V., Harvey, J. R., Wray, J., . . . North West Breast Research Collaborative. (2024). Breast cancer research gaps: a questionnaire-based study to determine overall priorities and compare the priorities of patients, the public, clinicians and scientists.. BMJ open, 14(8), e084573. doi:10.1136/bmjopen-2024-084573
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Lim, Y. J., Ward, V., Brown, A., Phillips, E., Kronsteiner, B., Malone, T., . . . Pettitt, A. (2024). Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.. British journal of haematology, 205(2), 440-451. doi:10.1111/bjh.19562
FERN: Is it possible to conduct a Randomised controlled trial of Intervention or Expectant Management for Early Onset Selective Fetal Growth Restriction in Monochorionic Twin Pregnancy: protocol for a prospective, mixed methods feasibility study
Sharp, A. (2024). FERN: Is it possible to conduct a Randomised controlled trial of Intervention or Expectant Management for Early Onset Selective Fetal Growth Restriction in Monochorionic Twin Pregnancy: protocol for a prospective, mixed methods feasibility study. BMJ Open.
Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.
Weinstein, D. A., Jackson, R. J., Brennan, E. A., Williams, M., Davison, J. E., Boer, F. D., . . . Mundy, H. R. (2024). Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.. Orphanet journal of rare diseases, 19(1), 258. doi:10.1186/s13023-024-03274-y
Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?
Pinto, A., Ahring, K., Almeida, M. F., Ashmore, C., Bélanger-Quintana, A., Burlina, A., . . . MacDonald, A. (2024). Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?. Nutrients, 16(13), 2064. doi:10.3390/nu16132064
Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial
Sharp, A., Cornforth, C., Jackson, R., Kenny, L., Alfirevic, Z., von dadelszen, P., . . . Harrold, J. (n.d.). Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology.
Comparison of Open Surgery and Endovascular Techniques for Juxtarenal and Complex Neck Aortic Aneurysms: The UK COMPlex AneurySm Study (UK-COMPASS) – Peri-operative and Midterm Outcomes
Vallabhaneni, S. R., Patel, S. R., Campbell, B., Boyle, J. R., Cook, A., Crosher, A., . . . Jackson, R. J. (2024). Comparison of Open Surgery and Endovascular Techniques for Juxtarenal and Complex Neck Aortic Aneurysms: The UK COMPlex AneurySm Study (UK-COMPASS) – Peri-operative and Midterm Outcomes. Journal of Vascular Surgery, 79(6), 1536. doi:10.1016/j.jvs.2024.04.009
Corrigendum to "A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone": [ESMO Open 8 (2023) 102033].
Pearson, J., Khan, A., Bhogal, T., Wong, H., Law, A., Mills, S., . . . Palmieri, C. (2024). Corrigendum to "A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone": [ESMO Open 8 (2023) 102033].. ESMO open, 9(6), 103621. doi:10.1016/j.esmoop.2024.103621
Abstract PO3-04-06: A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone
Pearson, J., Khan, A., Bhogal, T., Wong, H., Law, A., Mills, S., . . . Palmieri, C. (2024). Abstract PO3-04-06: A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone. Cancer Research, 84(9_Supplement). doi:10.1158/1538-7445.sabcs23-po3-04-06
Editor's Choice - Comparison of Open Surgery and Endovascular Techniques for Juxtarenal and Complex Neck Aortic Aneurysms: The UK COMPlex AneurySm Study (UK-COMPASS) - Peri-operative and Midterm Outcomes.
Vallabhaneni, S. R., Patel, S. R., Campbell, B., Boyle, J. R., Cook, A., Crosher, A., . . . Jackson, R. J. (2024). Editor's Choice - Comparison of Open Surgery and Endovascular Techniques for Juxtarenal and Complex Neck Aortic Aneurysms: The UK COMPlex AneurySm Study (UK-COMPASS) - Peri-operative and Midterm Outcomes.. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 67(4), 540-553. doi:10.1016/j.ejvs.2024.02.037
P.27 Impact of fruit and vegetable protein vs. milk protein on metabolic control of children with phenylketonuria: a randomized crossover controlled trial and 6 months follow-up
Pinto, A., Daly, A., Rocha, J. C., Ashmore, C., Evans, S., Jackson, R., . . . MacDonald, A. (2024). P.27 Impact of fruit and vegetable protein vs. milk protein on metabolic control of children with phenylketonuria: a randomized crossover controlled trial and 6 months follow-up. Molecular Genetics and Metabolism, 141, 108393. doi:10.1016/j.ymgme.2024.108393
A three-arm randomised Phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma
Sacco, J. J., Jackson, R., Corrie, P., Danson, S., Jeffry Evans, T. R., Ochsenreither, S., . . . Nathan, P. (2024). A three-arm randomised Phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma. European Journal of Cancer, 114009. doi:10.1016/j.ejca.2024.114009
Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease.
von Witzleben, A., Ellis, M., Thomas, G. J., Hoffmann, T. K., Jackson, R., Laban, S., & Ottensmeier, C. H. (2024). Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease.. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(1), 224-234. doi:10.1158/1078-0432.ccr-23-0445
2023
A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone.
Pearson, J., Khan, A., Bhogal, T., Wong, H., Law, A., Mills, S., . . . Palmieri, C. (2023). A comparison of the efficacy of trastuzumab deruxtecan in advanced HER2-positive breast cancer: active brain metastasis versus progressive extracranial disease alone.. ESMO open, 8(6), 102033. doi:10.1016/j.esmoop.2023.102033
Examining the effects of cytidine deaminase in pancreatic ductal adenocarcinoma cell lines and relation to gemcitabine and capecitabine efficacy
Rowley, W., Hale, J., Jackson, R., Costello-Goldring, E., Palmer, D., & Greenhalf, W. (2023). Examining the effects of cytidine deaminase in pancreatic ductal adenocarcinoma cell lines and relation to gemcitabine and capecitabine efficacy. Pancreatology, 23, e139-e140. doi:10.1016/j.pan.2023.06.758
Determining the Effectiveness of Fibrin Sealants in Reducing Complications in Patients Undergoing Lateral Neck Dissection (DEFeND): A Randomised External Pilot Trial.
Bajwa, M. S., Jackson, R., Dhanda, J., Tudur Smith, C., Shaw, R. J., & Schache, A. G. (2023). Determining the Effectiveness of Fibrin Sealants in Reducing Complications in Patients Undergoing Lateral Neck Dissection (DEFeND): A Randomised External Pilot Trial.. Cancers, 15(20), 5073. doi:10.3390/cancers15205073
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE)
Rajeev, S., Roberts, C., Brown, E., Sprung, V., Harrold, J., Halford, J., . . . Wilding, J. (2023). No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, cross-over trial (ENERGIZE). Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics. doi:10.1111/dom.15257
P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY
Jer Lim, Y., Ward, V., Farrell, L., Naisbitt, D., Brown, A., Phillips, E., . . . Pettitt, A. (n.d.). P1095: COVID-19 VACCINE RESPONSES IN FOLLICULAR LYMPHOMA: DETERMINANTS OF HUMORAL AND CELLULAR IMMUNITY IN THE PETREA TRIAL OF FRONTLINE CHEMOIMMUNOTHERAPY. HemaSphere, 7(S3), e49729ac. doi:10.1097/01.hs9.0000971276.49729.ac
Preliminary Data on Free Use of Fruits and Vegetables Containing Phenylalanine 76-100 mg/100 g of Food in 16 Children with Phenylketonuria: 6 Months Follow-Up
Pinto, A., Daly, A., Rocha, J. C., Ashmore, C., Evans, S., Jackson, R., . . . MacDonald, A. (2023). Preliminary Data on Free Use of Fruits and Vegetables Containing Phenylalanine 76-100 mg/100 g of Food in 16 Children with Phenylketonuria: 6 Months Follow-Up. NUTRIENTS, 15(13). doi:10.3390/nu15133046
Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection
Muinonen-Martin, A., Lee, R., Rothwell, D., Jackson, R., Smith, N., Wong, S., . . . Lorrigan, P. (2023). Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection. In BRITISH JOURNAL OF DERMATOLOGY Vol. 188. doi:10.1093/bjd/ljad113.084
THE HIPHOP STUDY: A FEASIBILITY STUDY FOR A RANDOMIZED CONTROLLED TRIAL OF HYBRID VERSUS CEMENTED TOTAL HIP ARTHROPLASTY
Board, T., Powell, R., Davies, A., Coffey, T., Wylde, V., Taylor, T., . . . Divecha, H. (2023). THE HIPHOP STUDY: A FEASIBILITY STUDY FOR A RANDOMIZED CONTROLLED TRIAL OF HYBRID VERSUS CEMENTED TOTAL HIP ARTHROPLASTY. Orthopaedic Proceedings, 105-B(SUPP_11), 34. doi:10.1302/1358-992x.2023.11.034
BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification.
Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (n.d.). BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification.. Molecular Cancer Research. doi:10.1158/1541-7786.mcr-22-0635
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma
de Andres, M. P., Jackson, R. J., Felipe, I., Zagorac, S., Pilarsky, C., Schlitter, A. M., . . . Real, F. X. (2023). GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma. GUT, 72(3), 535-548. doi:10.1136/gutjnl-2021-325803
Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG)-A phase I trial
Waqar, M., Roncaroli, F., Djoukhadar, I., Akkari, L., O'Leary, C., Hewitt, L., . . . Borst, G. R. (2023). Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG)-A phase I trial. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 39. doi:10.1016/j.ctro.2023.100585
2022
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.
Ghaneh, P., Palmer, D., Cicconi, S., Jackson, R., Halloran, C. M., Rawcliffe, C., . . . European Study Group for Pancreatic Cancer. (2022). Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.. The lancet. Gastroenterology & hepatology, S2468-1253(22)00348-X. doi:10.1016/s2468-1253(22)00348-x
Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer
Ponweera, A., Robinson, M., Jackson, R., Halloran, C., Palmer, D., Hackert, T., . . . Ghaneh, P. (2022). Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer. In BRITISH JOURNAL OF SURGERY Vol. 109. doi:10.1093/bjs/znac404.107
Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies
Braconi, D., Geminiani, M., Psarelli, E. E., Giustarini, D., Marzocchi, B., Rossi, R., . . . Santucci, A. (2022). Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies. CELLS, 11(22). doi:10.3390/cells11223668
CTNI-66. THE PREOPERATIVE BRAIN IRRADIATION IN GLIOBLASTOMA (POBIG) STUDY: A NOVEL TREATMENT PARADIGM TO IMPROVE OUTCOMES?
Borst, G., Waqar, M., McBain, C., Beasley, W., Golby, C., Hamerlik, P., . . . Roncaroli, F. (2022). CTNI-66. THE PREOPERATIVE BRAIN IRRADIATION IN GLIOBLASTOMA (POBIG) STUDY: A NOVEL TREATMENT PARADIGM TO IMPROVE OUTCOMES?. Neuro-Oncology, 24(Supplement_7), vii88. doi:10.1093/neuonc/noac209.331
Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer
Ponweera, A., Robinson, M., Jackson, R., Halloran, C., Palmer, D., Hackert, T., . . . Ghaneh, P. (2022). Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer. Pancreatology, 22, e58. doi:10.1016/j.pan.2022.06.149
Stratified comparisons of Gemcitabine plus Capecitabine against Gemcitabine alone; further results from the ESPAC-4 trial
Jackson, R., Ghaneh, P., Halloran, C., Palmer, D., Hackert, T., Costello, E., . . . Neoptolemos, J. (2022). Stratified comparisons of Gemcitabine plus Capecitabine against Gemcitabine alone; further results from the ESPAC-4 trial. Pancreatology, 22, e79-e80. doi:10.1016/j.pan.2022.06.206
[A04] Is a 14 Day Delay Necessary when Treating Uncomplicated Type B Aortic Dissection with Thoracic Endovascular Aneurysm Repair? A Systematic Review and Meta-analysis
Patel, S., Hossack, M., Jackson, R., & Vallabhaneni, S. R. (2022). [A04] Is a 14 Day Delay Necessary when Treating Uncomplicated Type B Aortic Dissection with Thoracic Endovascular Aneurysm Repair? A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery, 64(5), e55. doi:10.1016/j.ejvs.2022.07.031
Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
Imrich, R., Sedlakova, J., Ulehlova, M., Gornall, M., Jackson, R., Olsson, B., . . . Ranganath, L. R. (2022). Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone. RMD OPEN, 8(2). doi:10.1136/rmdopen-2022-002422
Impact of Fruit and Vegetable Protein vs. Milk Protein on Metabolic Control of Children with Phenylketonuria: A Randomized Crossover Controlled Trial
Pinto, A., Daly, A., Rocha, J. C., Ashmore, C., Evans, S., Jackson, R., . . . MacDonald, A. (2022). Impact of Fruit and Vegetable Protein vs. Milk Protein on Metabolic Control of Children with Phenylketonuria: A Randomized Crossover Controlled Trial. NUTRIENTS, 14(20). doi:10.3390/nu14204268
United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer
Oldfield, L., Stott, M., Hanson, R., Jackson, R. J., Reynolds, W., Chandran-Gorner, V., . . . Costello, E. (2022). United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer. BMJ OPEN, 12(10). doi:10.1136/bmjopen-2022-068010
A COMPARISON OF DISEASE MODELS IN HEPATOCELLULAR CARCINOMA TO STUDY VARIATIONS WITHIN BARCELONA CLINIC LIVER CANCER STAGING TO REFINE PROGNOSIS AND CLINICAL DECISION
Balachandrakumar, V., Jackson, R., Stern, N., Evans, J., Chan, T., O'Grady, E., . . . Cross, T. J. S. (2022). A COMPARISON OF DISEASE MODELS IN HEPATOCELLULAR CARCINOMA TO STUDY VARIATIONS WITHIN BARCELONA CLINIC LIVER CANCER STAGING TO REFINE PROGNOSIS AND CLINICAL DECISION. In GUT Vol. 71 (pp. A45-A46). doi:10.1136/gutjnl-2022-BASL.71
A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.
Halloran, C. M., Neoptolemos, J. P., Jackson, R., Platt, K., Psarelli, E. -E., Reddy, S., . . . Ghaneh, P. (2022). A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 3(3), e198. doi:10.1097/as9.0000000000000198
Postoperative Packing of Perianal Abscess Cavities PPAC2 randomized clinical trial
Newton, K., Dumville, J., Briggs, M., Law, J., Martin, J., Pearce, L., . . . Hill, J. (2022). Postoperative Packing of Perianal Abscess Cavities PPAC2 randomized clinical trial. BRITISH JOURNAL OF SURGERY, 109(10), 951-957. doi:10.1093/bjs/znac225
Web-Based Psychological Interventions for People Living With and Beyond Cancer: Meta-Review of What Works and What Does Not for Maximizing Recruitment, Engagement, and Efficacy.
Leslie, M., Beatty, L., Hulbert-Williams, L., Pendrous, R., Cartwright, T., Jackson, R., . . . Hulbert-Williams, N. J. (2022). Web-Based Psychological Interventions for People Living With and Beyond Cancer: Meta-Review of What Works and What Does Not for Maximizing Recruitment, Engagement, and Efficacy.. JMIR cancer, 8(3), e36255. doi:10.2196/36255
Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience
Hall, B. J., Bhojwani, A. A., Wong, H., Law, A., Flint, H., Ahmed, E., . . . Palmieri, C. (2022). Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience. BREAST JOURNAL, 2022. doi:10.1155/2022/7146172
Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis
Patel, S. R., Ormesher, D. C., Griffin, R., Jackson, R. J., Lip, G. Y. H., & Vallabhaneni, S. R. (2022). Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis. Journal of Vascular Surgery, 75(6), 2097. doi:10.1016/j.jvs.2022.04.016
DETECTION phase II/III trial: Circulating tumor DNA–guided therapy for stage IIB/C melanoma after surgical resection.
Lee, R., Rothwell, D. G., Jackson, R., Smith, N., Wong, S. Q., Kelso, N., . . . Lorigan, P. (2022). DETECTION phase II/III trial: Circulating tumor DNA–guided therapy for stage IIB/C melanoma after surgical resection.. Journal of Clinical Oncology, 40(16_suppl), TPS9603. doi:10.1200/jco.2022.40.16_suppl.tps9603
Efficacy of a New Low-Protein Multimedia Diet App for PKU
Evans, S., Ashmore, C., Daly, A., Dhadwar, P., Syed, A., Lecocq, O., . . . MacDonald, A. (2022). Efficacy of a New Low-Protein Multimedia Diet App for PKU. NUTRIENTS, 14(11). doi:10.3390/nu14112182
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial
Hussain, S. A., Lester, J. F., Jackson, R., Gornall, M., Qureshi, M., Elliott, A., . . . Jones, R. J. (2022). Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. LANCET ONCOLOGY, 23(5), 650-658. doi:10.1016/S1470-2045(22)00158-9
Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis
Patel, S. R., Ormesher, D. C., Griffin, R., Jackson, R. J., Lip, G. Y. H., & Vallabhaneni, S. R. (2022). Comparison of Open, Standard, and Complex Endovascular Aortic Repair Treatments for Juxtarenal/Short Neck Aneurysms: A Systematic Review and Network Meta-Analysis. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 63(5), 696-706. doi:10.1016/j.ejvs.2021.12.042
Kernel hazard estimation for visualisation of the effect of a continuous covariates on time-to-event endpoints
Jackson, R. J., & Cox, T. F. (2022). Kernel hazard estimation for visualisation of the effect of a continuous covariates on time-to-event endpoints. PHARMACEUTICAL STATISTICS, 21(3), 514-524. doi:10.1002/pst.2183
Salbutamol for analgesia in renal colic: study protocol for a prospective, randomised, placebo-controlled phase II trial (SARC).
Johnson, G., Tabner, A., Fakis, A., Sherman, R., Chester, V., Bedford, E., . . . Mason, S. (2022). Salbutamol for analgesia in renal colic: study protocol for a prospective, randomised, placebo-controlled phase II trial (SARC).. Trials, 23(1), 352. doi:10.1186/s13063-022-06225-9
Validation of a Low-protein Semi-Quantitative Food Frequency Questionnaire
Evans, S., Ashmore, C., Daly, A., Jackson, R., Pinto, A., & MacDonald, A. (2022). Validation of a Low-protein Semi-Quantitative Food Frequency Questionnaire. NUTRIENTS, 14(8). doi:10.3390/nu14081595
A single centre's experience of 23 cases of total rhinectomy for the treatment of squamous cell carcinoma involving the nasal vestibule
Chabrillac, E., Talawdekar, A., Garikipati, S., Varley, I., Sionis, S., Beasley, N., & Jackson, R. (2022). A single centre's experience of 23 cases of total rhinectomy for the treatment of squamous cell carcinoma involving the nasal vestibule. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 279(4), 2069-2075. doi:10.1007/s00405-021-06972-6
Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria
Ranganath, L. R., Milan, A. M., Hughes, A. T., Davison, A. S., Khedr, M., Norman, B. P., . . . Olsson, B. (2022). Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria. Molecular Genetics and Metabolism Reports, 30, 100846. doi:10.1016/j.ymgmr.2022.100846
Salbutamol for analgesia in renal colic: A prospective, randomised, placebo-controlled Phase II trial (SARC)
Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria-An approach using statistical modelling.
Ranganath, L. R., Milan, A. M., Hughes, A. T., Khedr, M., Norman, B. P., Alsbou, M., . . . Jackson, R. (2022). Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria-An approach using statistical modelling.. JIMD reports, 63(1), 80-92. doi:10.1002/jmd2.12261
2021
A risk-adjusted and anatomically stratified cohort comparison study of open surgery, endovascular techniques and medical management for juxtarenal aortic aneurysms-the UK COMPlex AneurySm Study (UK-COMPASS): a study protocol.
Patel, S. R., Ormesher, D. C., Smith, S. R., Wong, K. H. F., Bevis, P., Bicknell, C. D., . . . Vallabhaneni, S. R. (2021). A risk-adjusted and anatomically stratified cohort comparison study of open surgery, endovascular techniques and medical management for juxtarenal aortic aneurysms-the UK COMPlex AneurySm Study (UK-COMPASS): a study protocol.. BMJ open, 11(11), e054493. doi:10.1136/bmjopen-2021-054493
Predictors of relapse in MOG antibody associated disease: a cohort study
Huda, S., Whittam, D., Jackson, R., Karthikeayan, V., Kelly, P., Linaker, S., . . . Jacob, A. (2021). Predictors of relapse in MOG antibody associated disease: a cohort study. BMJ OPEN, 11(11). doi:10.1136/bmjopen-2021-055392
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
Aughton, K., Elander, N. O., Evans, A., Jackson, R., Campbell, F., Costello, E., . . . Greenhalf, W. (2021). hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. CANCERS, 13(22). doi:10.3390/cancers13225758
Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study
Clifford, R. E., Harji, D., Poynter, L., Jackson, R., Adams, R., Fearnhead, N. S., & Vimalachandran, D. (2021). Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study. BRITISH JOURNAL OF SURGERY, 108(11), 1270-1273. doi:10.1093/bjs/znab129
Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery
Schache, A. G., Shaw, R., Ho, M. W. S., Winter, S. C., Glasbey, J., Ganly, I., . . . SICO, I. S. S. O. (2021). Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery. BJS OPEN, 5(6). doi:10.1093/bjsopen/zrab112
K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy
Schoeler, N. E., Orford, M., Vivekananda, U., Simpson, Z., Van de Bor, B., Smith, H., . . . Walker, M. C. (2021). K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy. BRAIN COMMUNICATIONS, 3(4). doi:10.1093/braincomms/fcab160
The Finding My Way UK Clinical Trial: Adaptation Report and Protocol for a Replication Randomized Controlled Efficacy Trial of a Web-Based Psychological Program to Support Cancer Survivors.
Hulbert-Williams, N. J., Leslie, M., Hulbert-Williams, L., Koczwara, B., Watson, E. K., Hall, P. S., . . . Beatty, L. (2021). The Finding My Way UK Clinical Trial: Adaptation Report and Protocol for a Replication Randomized Controlled Efficacy Trial of a Web-Based Psychological Program to Support Cancer Survivors.. JMIR research protocols, 10(9), e31976. doi:10.2196/31976
Physical Growth of Patients with Hereditary Tyrosinaemia Type I: A Single-Centre Retrospective Study
Yilmaz, O., Daly, A., Pinto, A., Ashmore, C., Evans, S., Gupte, G., . . . MacDonald, A. (2021). Physical Growth of Patients with Hereditary Tyrosinaemia Type I: A Single-Centre Retrospective Study. NUTRIENTS, 13(9). doi:10.3390/nu13093070
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma
<i>Drosophila</i> USP22/nonstop polarizes the actin cytoskeleton during collective border cell migration
Badmos, H., Cobbe, N., Campbell, A., Jackson, R., & Bennett, D. (2021). <i>Drosophila</i> USP22/nonstop polarizes the actin cytoskeleton during collective border cell migration. JOURNAL OF CELL BIOLOGY, 220(7). doi:10.1083/jcb.202007005
SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol
McCarthy, C., Sacco, J., Fedele, S., Ho, M., Porter, S., Liloglou, T., . . . Shaw, R. (2021). SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. TRIALS, 22(1). doi:10.1186/s13063-021-05373-8
Abstract 1193: Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials
Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2021). Abstract 1193: Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials. Cancer Research, 81(13_Supplement), 1193. doi:10.1158/1538-7445.am2021-1193
GATA4 and GATA6 cooperate to drive tumor biology and patient outcome in human PDAC
De Andres, M. P., Jackson, R., Greenhalf, W., Kloesch, B., Schlitter, A. M., Costello, E., . . . Real, F. X. (2021). GATA4 and GATA6 cooperate to drive tumor biology and patient outcome in human PDAC. Pancreatology, 21, S6-S7. doi:10.1016/j.pan.2021.05.024
Prognostic impact of CA 19-9 levels in patients with resectable pancreatic cancer who receive adjuvant chemotherapy in randomized controlled trials: A systematic review
Robinson, M., Ponweera, A., Jackson, R., Halloran, C., & Ghaneh, P. (2021). Prognostic impact of CA 19-9 levels in patients with resectable pancreatic cancer who receive adjuvant chemotherapy in randomized controlled trials: A systematic review. Pancreatology, 21, S87. doi:10.1016/j.pan.2021.05.236
Recruitment pathways in the UK early detection initiative (UK-EDI) for pancreatic cancer study
Stott, M., Hanson, R., Oldfield, L., Greenhalf, W., Van Der Meer, R., Allison, L., . . . Costello, E. (2021). Recruitment pathways in the UK early detection initiative (UK-EDI) for pancreatic cancer study. Pancreatology, 21, S109. doi:10.1016/j.pan.2021.05.291
The detoxifying enzyme NQO1 and chemotherapy response prediction in pancreatic cancer
Patel, C., Williams, D., Gana, T., Evans, A., Jackson, R., Campbell, F., . . . Costello, E. (2021). The detoxifying enzyme NQO1 and chemotherapy response prediction in pancreatic cancer. Pancreatology, 21, S69-S70. doi:10.1016/j.pan.2021.05.186
A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes
Daly, A., Hoegler, W., Crabtree, N., Shaw, N., Evans, S., Pinto, A., . . . MacDonald, A. (2021). A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes. NUTRIENTS, 13(6). doi:10.3390/nu13062075
<i>In vitro</i> elution characteristics of gentamicin- and teicoplanin-loaded CMW1 and Palacos R bone cement.
Nagy, M., Jakaraddi, C., Neal, T., Jackson, R., Navin, A., Davidson, J. S., & Santini, A. J. A. (2021). <i>In vitro</i> elution characteristics of gentamicin- and teicoplanin-loaded CMW1 and Palacos R bone cement.. Journal of orthopaedics, 25, 75-81. doi:10.1016/j.jor.2021.03.024
Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes
Daly, A., Hoegler, W., Crabtree, N., Shaw, N., Evans, S., Pinto, A., . . . MacDonald, A. (2021). Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes. NUTRIENTS, 13(4). doi:10.3390/nu13041323
Growth and Body Composition in PKU Children—A 3 Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes
Reply to Mathew
Fowler, H., Clifford, R. E., Sutton, P., Watson, A. J. M., Fearnhead, N., Rose, A., . . . Vimalachandran, D. (2021). Reply to Mathew. COLORECTAL DISEASE, 23(3), 752-753. doi:10.1111/codi.15490
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.
Bhogal, T., Khan, U. T., Lee, R., Stockdale, A., Hesford, C., Potti-Dhananjaya, V., . . . Palmieri, C. (2021). Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.. Leukemia & lymphoma, 1-16. doi:10.1080/10428194.2021.1876865
Cervical cerclage, pessary, or vaginal progesterone in high-risk pregnant women with short cervix: a randomized feasibility study
Care, A., Jackson, R., O'Brien, E., Leigh, S., Cornforth, C., Haycox, A., . . . Alfirevic, Z. (2021). Cervical cerclage, pessary, or vaginal progesterone in high-risk pregnant women with short cervix: a randomized feasibility study. JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 34(1), 49-57. doi:10.1080/14767058.2019.1588245
2020
Head and neck cancer surgery during the COVID-19 pandemic: an international, multicentre, observational cohort study
Shaw, R., Schache, A., Jackson, R., & Ciccone, S. (2020). Head and neck cancer surgery during the COVID-19 pandemic: an international, multicentre, observational cohort study. Cancer. doi:10.1002/cncr.33320
Hartmann's procedure versus intersphincteric abdominoperineal excision (HiP Study): a multicentre prospective cohort study
Fowler, H., Clifford, R., Sutton, P., Watson, A., Fearnhead, N., Bach, S., . . . Vimalachandran, D. (2020). Hartmann's procedure versus intersphincteric abdominoperineal excision (HiP Study): a multicentre prospective cohort study. COLORECTAL DISEASE, 22(12), 2114-2122. doi:10.1111/codi.15366
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.
Pettitt, A. R., Jackson, R., Cicconi, S., Polydoros, F., Yap, C., Dodd, J., . . . Hillmen, P. (2020). Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.. Haematologica, 105(12), 2868-2871. doi:10.3324/haematol.2019.230805
The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32+0weeks' gestation
Gent, J., Bullough, S., Harrold, J., Jackson, R., Woolfall, K., Andronis, L., . . . Sharp, A. (2020). The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32+0weeks' gestation. PILOT AND FEASIBILITY STUDIES, 6(1). doi:10.1186/s40814-020-00722-x
GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials
Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2020). GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials. In CANCER RESEARCH Vol. 80. doi:10.1158/1538-7445.PANCA20-PO-005
Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
Brenner, A., Belli, A., Chaudhri, R., Coats, T., Frimley, L., Jamaluddin, S. F., . . . CRASH-3 trial collaborators. (2020). Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.. Critical care (London, England), 24(1), 560. doi:10.1186/s13054-020-03243-4
PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results.
Halloran, C., Neoptolemos, J. P., Platt, K., Jackson, R., Reddy, S., Oreily, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38. Retrieved from https://www.webofscience.com/
The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
Daly, A., Evans, S., Pinto, A., Jackson, R., Ashmore, C., Rocha, J. C., & MacDonald, A. (2020). The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria. NUTRIENTS, 12(9). doi:10.3390/nu12092704
Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria
Daly, A., Evans, S., Pinto, A., Jackson, R., Ashmore, C., Rocha, J. C., & MacDonald, A. (2020). Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria. NUTRIENTS, 12(8). doi:10.3390/nu12082443
An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
Baker, J., Dickman, A., Mason, S., Bickerstaff, M., Jackson, R., McArdle, A., . . . Ellershaw, J. (2020). An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?. BMC PALLIATIVE CARE, 19(1). doi:10.1186/s12904-020-00611-3
Determining the effectiveness of fibrin sealants in reducing complications in patients undergoing lateral neck dissection (DEFeND): Study protocol for a randomised external pilot trial
Bajwa, M. S., Carruthers, S., Hanson, R., Jackson, R., Braithwaite, C., Edwards, M., . . . Schache, A. G. (2020). Determining the effectiveness of fibrin sealants in reducing complications in patients undergoing lateral neck dissection (DEFeND): Study protocol for a randomised external pilot trial. Pilot and Feasibility Studies, 6(1). doi:10.1186/s40814-020-00618-w
PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy—A double-blinded multi-centered trial, trial results.
Halloran, C., Neoptolemos, J. P., Platt, K., Jackson, R., Reddy, S., Oreilly, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy—A double-blinded multi-centered trial, trial results.. Journal of Clinical Oncology, 38(15_suppl), 4619. doi:10.1200/jco.2020.38.15_suppl.4619
Phase II randomized placebo-controlled neoadjuvant trial of nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer (NEO-BLADE).
Hussain, S. A., Lester, J. F., Jackson, R., Gornall, M., Elliott, A., Crabb, S. J., . . . Jones, R. J. (2020). Phase II randomized placebo-controlled neoadjuvant trial of nintedanib or placebo with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer (NEO-BLADE).. Journal of Clinical Oncology, 38(6_suppl), 438. doi:10.1200/jco.2020.38.6_suppl.438
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial
Pettitt, A. R., Jackson, R., Cicconi, S., Polydoros, F., Yap, C., Dodd, J., . . . Hillmen, P. (2020). Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial. HAEMATOLOGICA, 105(12), 2868-2871. doi:10.3324/haematol.2019.230805
Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial
Khalil, A., Sharp, A. N., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2020). Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early‐onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo‐controlled double‐blind trial. Ultrasound in Obstetrics and Gynecology, 55(2), 198-209. doi:10.1002/uog.20851
Diagnostic accuracy of 18 FDG PET/CT in the evaluation of suspicious pancreatic cysts
Mohamed, E., Jackson, R., & Ghaneh, P. (2020). Diagnostic accuracy of 18 FDG PET/CT in the evaluation of suspicious pancreatic cysts. HPB, 22, S360-S361. doi:10.1016/j.hpb.2020.04.382
2019
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
CRASH-3 trial collaborators. (2019). Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.. Lancet (London, England), 394(10210), 1713-1723. doi:10.1016/s0140-6736(19)32233-0
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
Jones, R. P., Psarelli, E. -E., Jackson, R., Ghaneh, P., Halloran, C. M., Palmer, D. H., . . . Millat, B. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154(11), 1038-1048. doi:10.1001/jamasurg.2019.3337
A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction
Sharp, A., Jackson, R., Cornforth, C., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (2019). A Prediction Model for Short-Term Neonatal Outcomes in Severe Early-Onset Fetal Growth Restriction. European Journal of Obstetrics and Gynecology and Reproductive Biology, 241, 109-118. doi:10.1016/j.ejogrb.2019.08.007
Functional outcome of total hip arthroplasty after a previous hip arthroscopy: a retrospective comparative cohort study
Jain, M. V., Rajpura, A., Kumar, V. S., Shaw, D., Al Najjar, M., Kalsi, N. K., . . . Board, T. N. (2019). Functional outcome of total hip arthroplasty after a previous hip arthroscopy: a retrospective comparative cohort study. HIP INTERNATIONAL, 29(4), 363-367. doi:10.1177/1120700018810509
NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESPONSE‐ADAPTED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, ADVANCED‐STAGE, HIGH‐TUMOUR‐BURDEN FOLLICULAR LYMPHOMA
Pettitt, A. R., Barrington, S., Kalakonda, N., Khan, U. T., Jackson, R., Carruthers, S., . . . Trotman, J. (2019). NCRI PETREA TRIAL: A PHASE 3 EVALUATION OF PET‐GUIDED, RESPONSE‐ADAPTED THERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, ADVANCED‐STAGE, HIGH‐TUMOUR‐BURDEN FOLLICULAR LYMPHOMA. Hematological Oncology, 37(S2), 67-68. doi:10.1002/hon.35_2629
Real-world data regarding the efficacy of neoadjuvant carboplatin-paclitaxel followed by dose-dense adriamycin-cyclophosphamide for triple-negative early breast cancer.
Bhojwani, A. A., Flint, H., Hall, B. J., Wong, H., Innes, H., Cliff, J., . . . Palmieri, C. (2019). Real-world data regarding the efficacy of neoadjuvant carboplatin-paclitaxel followed by dose-dense adriamycin-cyclophosphamide for triple-negative early breast cancer.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 37. doi:10.1200/JCO.2019.37.15_suppl.e12559
Real-world evidence regarding the efficacy and toxicity of neoadjuvant trastuzumab and pertuzumab in the management of HER2-positive early-breast cancer.
Hall, B. J., Bhojwani, A. A., Innes, H., Ahmed, E., Cliff, J., Malik, Z., . . . Palmieri, C. (2019). Real-world evidence regarding the efficacy and toxicity of neoadjuvant trastuzumab and pertuzumab in the management of HER2-positive early-breast cancer.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 37. doi:10.1200/JCO.2019.37.15_suppl.e12108
Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria
Pinto, A., Almeida, M. F., MacDonald, A., Ramos, P. C., Rocha, S., Guimas, A., . . . Rocha, J. C. (2019). Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria. NUTRIENTS, 11(5). doi:10.3390/nu11050995
Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma
Mann, K., Gilbert, T., Cicconi, S., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2019). Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. LANGENBECKS ARCHIVES OF SURGERY, 404(4), 439-449. doi:10.1007/s00423-019-01779-w
The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool
Olsson-Brown, A., Piskilidis, P., O'Hagan, J., Thorp, N., Robson, P., Innes, H., . . . Palmieri, C. (2019). The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision Tool. BREAST, 44, 94-100. doi:10.1016/j.breast.2019.01.005
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery.
Shaw, R. J., Butterworth, C. J., Silcocks, P., Tesfaye, B. T., Bickerstaffe, M., Jackson, R., . . . Glover, M. (2019). HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery.. International journal of radiation oncology, biology, physics. doi:10.1016/j.ijrobp.2019.02.044
Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction
Sharp, A., Cornforth, C., Jackson, R., Harrold, J., Turner, M. A., Kenny, L., . . . Alfirevic, Z. (2019). Mortality in the UK STRIDER trial of sildenafil therapy for the treatment of severe early-onset fetal growth restriction. LANCET CHILD & ADOLESCENT HEALTH, 3(3), E2-E3. doi:10.1016/S2352-4642(19)30020-3
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma
Ghaneh, P., Kleeff, J., Halloran, C. M., Raraty, M., Jackson, R., Melling, J., . . . Smith, C. (2019). The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 269(03), 520-529. doi:10.1097/SLA.0000000000002557
The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial
Daly, A., Evans, S., Chahal, S., Santra, S., Pinto, A., Gingell, C., . . . MacDonald, A. (2019). The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial. NUTRIENTS, 11(3). doi:10.3390/nu11030520
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
Daly, A., Evans, S., Chahal, S., Santra, S., Pinto, A., Jackson, R., . . . MacDonald, A. (2019). Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU. ORPHANET JOURNAL OF RARE DISEASES, 14. doi:10.1186/s13023-019-1011-y
Profiling the early haematological dynamics and treatment modifications with palbociclib when used as first line treatment for ER-positive, HER2-negative metastatic breast cancer
Bhojwani, A., Flint, H., Hall, B., Wong, H., Innes, H., Cliff, J., . . . Palmieri, C. (2019). Profiling the early haematological dynamics and treatment modifications with palbociclib when used as first line treatment for ER-positive, HER2-negative metastatic breast cancer. In CANCER RESEARCH Vol. 79. doi:10.1158/1538-7445.SABCS18-P6-18-32
Real world experience of the medical and surgical management of HER2 positive early breast cancer treated with neoadjuvant trastuzumab and pertuzumab via the NHS England cancer drug fund
Hall, B., Bhojwani, A., Innes, H., Ahmed, E., Cliff, J., Malik, Z., . . . Palmieri, C. (2019). Real world experience of the medical and surgical management of HER2 positive early breast cancer treated with neoadjuvant trastuzumab and pertuzumab via the NHS England cancer drug fund. In CANCER RESEARCH Vol. 79. doi:10.1158/1538-7445.SABCS18-P6-17-27
Comparison of clinical outcomes in anterior cervical discectomy versus foraminotomy for brachialgia
Foster, M. T., Carleton-Bland, N. P., Lee, M. K., Jackson, R., Clark, S. R., & Wilby, M. J. (2019). Comparison of clinical outcomes in anterior cervical discectomy versus foraminotomy for brachialgia. BRITISH JOURNAL OF NEUROSURGERY, 33(1), 3-7. doi:10.1080/02688697.2018.1527013
Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.
Sheel, A. R. G., Harrison, S., Sarantitis, I., Nicholson, J. A., Hanna, T., Grocock, C., . . . Greenhalf, W. (2019). Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.. The American Journal of Gastroenterology (Elsevier), 114(1), 155-164. doi:10.1038/s41395-018-0395-y
2018
81. Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial
Khalil, A., Sharp, A., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2018). 81. Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial. Pregnancy Hypertension, 13, S70. doi:10.1016/j.preghy.2018.08.207
OP19.10: Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial
Khalil, A., Sharp, A., Cornforth, C., Jackson, R., Mousa, H., Stock, S., . . . Alfirevic, Z. (2018). OP19.10: Maternal cardiovascular changes secondary to sildenafil intake in pregnancies complicated by severe fetal growth restriction: STRIDER trial. Ultrasound in Obstetrics & Gynecology, 52(S1), 125. doi:10.1002/uog.19574
Role of Radiological Imaging in the Diagnosis and Characterization of Pancreatic Cystic Lesions: A Systematic Review
Mohamed, E., Jackson, R., Halloran, C. M., & Ghaneh, P. (2018). Role of Radiological Imaging in the Diagnosis and Characterization of Pancreatic Cystic Lesions: A Systematic Review. PANCREAS, 47(9), 1055-1064. doi:10.1097/MPA.0000000000001134
The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis
Sheel, A. R. G., Baron, R. D., Sarantitis, I., Ramesh, J., Ghaneh, P., Raraty, M. G. T., . . . Neoptolemos, J. P. (2018). The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis. PANCREATOLOGY, 18(7), 774-784. doi:10.1016/j.pan.2018.08.002
Longitudinal deprivation trajectories and risk of cardiovascular disease in New Zealand
Shackleton, N., Darlington-Pollock, F., Norman, P., Jackson, R., & Exeter, D. J. (2018). Longitudinal deprivation trajectories and risk of cardiovascular disease in New Zealand. HEALTH & PLACE, 53, 34-42. doi:10.1016/j.healthplace.2018.07.010
Biomarker predication of efficacy to gemcitabine plus vandetanib in phase II, double blind multicentre randomised controlled trial of gemcitabine placebo in locally advanced or metastatic pancreatic carcinoma
Evans, A., Jackson, R., Shaw, V. E., Ghaneh, P., Wadsley, J., Valle, J. W., . . . Middleton, G. (2018). Biomarker predication of efficacy to gemcitabine plus vandetanib in phase II, double blind multicentre randomised controlled trial of gemcitabine placebo in locally advanced or metastatic pancreatic carcinoma. Pancreatology, 18(4), S127-S128. doi:10.1016/j.pan.2018.05.343
Predictors of sorafenib benefit in patients with hepatocellular carcinoma
Jackson, R., Psarelli, E., Berhane, S., & Johnson, P. J. (2018). Predictors of sorafenib benefit in patients with hepatocellular carcinoma. Journal of Hepatology, 68(3), 619-620. doi:10.1016/j.jhep.2017.09.028
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial
Sharp, A., Cornforth, C., Turner, M. A., Harrold, J., Kenny, L. C., Jackson, R., . . . Alfirevic, Z. (2018). Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child and Adolescent Health, 2(2), 93-102. doi:10.1016/S2352-4642(17)30173-6
2017
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials
Pels, A., Kenny, L. C., Alfirevic, Z., Baker, P. N., von Dadelszen, P., Gluud, C., . . . Groom, K. M. (2017). STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials. BMC PREGNANCY AND CHILDBIRTH, 17. doi:10.1186/s12884-017-1594-z
A Bayesian meta-analysis of multiple treatment comparisons of pancreatic duct stent drainage for pancreaticoduodenectomy
Yin, J., Lu, Z., Jackson, R., Zhang, K., Jiang, K., & Miao, Y. (2017). A Bayesian meta-analysis of multiple treatment comparisons of pancreatic duct stent drainage for pancreaticoduodenectomy. Pancreatology, 17(4), S28. doi:10.1016/j.pan.2017.07.095
OC01.05: STRIDER UK: a randomised controlled trial of sildenafil therapy in dismal prognosis early‐onset intrauterine growth restriction
Sharp, A., Comforth, C., Jackson, R., Turner, M., Kenny, L., Baker, P., . . . Alfirevic, Z. (2017). OC01.05: STRIDER UK: a randomised controlled trial of sildenafil therapy in dismal prognosis early‐onset intrauterine growth restriction. Ultrasound in Obstetrics & Gynecology, 50(S1), 3. doi:10.1002/uog.17574
Missed pancreatic ductal adenocarcinoma (PDAC) in Hereditary Pancreatitis (HP) kindreds indicate the importance of a systematic approach to secondary screening
Sheel, A., Harrison, S., Sarantitis, I., Nicholson, J., Halloran, C., Raraty, M., . . . Greenhalf, W. (2017). Missed pancreatic ductal adenocarcinoma (PDAC) in Hereditary Pancreatitis (HP) kindreds indicate the importance of a systematic approach to secondary screening. Pancreatology, 17(3), S66. doi:10.1016/j.pan.2017.05.209
Reply to N. Personeni et al
Jackson, R., Psarelli, E., & Johnson, P. J. (2017). Reply to N. Personeni et al. Journal of Clinical Oncology, 35(19), 2214. doi:10.1200/JCO.2017.72.9293
Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial
Shakur, H., Roberts, I., Fawole, B., Chaudhri, R., El-Sheikh, M., Akintan, A., . . . Coordinators, N. (2017). Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. The Lancet, 389(10084), 2105-2116. doi:10.1016/S0140-6736(17)30638-4
Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo controlled trial in locally advanced or metastatic pancreatic carcinoma.
Neoptolemos, J. P., Palmer, D., Greenhalf, W., Ghaneh, P., Jackson, R., Evans, A., . . . Middleton, G. W. (2017). Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo controlled trial in locally advanced or metastatic pancreatic carcinoma.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35. doi:10.1200/JCO.2017.35.15_suppl.4104
Beyond ESPAC-4: better surgery and systemic therapy
Psarelli, E. E., Jackson, R., Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Halloran, C. M., & Buechler, M. W. (2017). Beyond ESPAC-4: better surgery and systemic therapy. LANCET, 389(10078), 1517-1518. doi:10.1016/S0140-6736(17)30947-9
Diagnostic accuracy of individual antenatal tools for prediction of small‐for‐gestational age at birth
Poljak, B., Agarwal, U., Jackson, R., Alfirevic, Z., & Sharp, A. N. (2017). Diagnostic accuracy of individual antenatal tools for prediction of small‐for‐gestational age at birth. Ultrasound in Obstetrics and Gynecology, 49(4), 493-499. doi:10.1002/uog.17211
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
Middleton, G., Palmer, D. H., Greenhalf, W., Ghaneh, P., Jackson, R., Cox, T., . . . Neoptolemos, J. P. (2017). Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. The Lancet Oncology, 18(4), 486-499. doi:10.1016/S1470-2045(17)30084-0
Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability
Dickman, A., Bickerstaff, M., Jackson, R., Schneider, J., Mason, S., & Ellershaw, J. (2017). Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability. BMC PALLIATIVE CARE, 16. doi:10.1186/s12904-017-0195-y
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., . . . Büchler, M. W. (2017). Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.. Lancet (London, England), 389(10073), 1011-1024. doi:10.1016/s0140-6736(16)32409-6
VICTOR: Vinflunine (Vin) in advanced metastatic transitional cell carcinoma of the urothelium (TCCU)-A retrospective analysis of use of Vin in multicenter, real life setting as second-line chemotherapy (ChT) through free-of charge-programme (FOCP) for patients (pts) in the UK
Hussain, S. A., Ansari, J., Huddart, R. A., Wylie, J., Vilarino-Varela, M., Faust, G., . . . Jackson, R. (2015). VICTOR: Vinflunine (Vin) in advanced metastatic transitional cell carcinoma of the urothelium (TCCU)-A retrospective analysis of use of Vin in multicenter, real life setting as second-line chemotherapy (ChT) through free-of charge-programme (FOCP) for patients (pts) in the UK. In JOURNAL OF CLINICAL ONCOLOGY Vol. 33. doi:10.1200/jco.2015.33.7_suppl.352
Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials
Jackson, R., Psarelli, E. E., Berhane, S., Khan, H., & Johnson, P. J. (2017). Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials. Journal of Clinical Oncology, 35(6), 622-628. doi:10.1200/JCO.2016.69.5197
Thrombo-embolic events (TEE) during neoadjuvant chemotherapy for muscle invasive bladder cancer.
Hussain, S. A., Gomberg, S., Probert, C., Hickerton, B., Jackson, R., & Weston, R. (2017). Thrombo-embolic events (TEE) during neoadjuvant chemotherapy for muscle invasive bladder cancer.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35. doi:10.1200/JCO.2017.35.6_suppl.339
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Law, P. J., Berndt, S. I., Speedy, H. E., Camp, N. J., Sava, G. P., Skibola, C. F., . . . Slager, S. (2017). Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nature Communications, 8. doi:10.1038/ncomms14175
Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: A meta-analysis of randomised phase III trials
Johnson, P. J., Jackson, R., Berhane, S., & Psarelli, E. (2017). Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: A meta-analysis of randomised phase III trials. Journal of Clinical Oncology. doi:10.1200/JCO.2016.69.5197
2016
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
Kleeff, J., Costello, E., Jackson, R., Halloran, C., Greenhalf, W., Ghaneh, P., . . . Neoptolemos, J. P. (2016). The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer. BRITISH JOURNAL OF CANCER, 115(7), 887-894. doi:10.1038/bjc.2016.277
Effect of antecolic or retrocolic route of gastroenteric anastomosis on delayed gastric emptying after pancreaticoduodenectomy: A meta-analysis of randomized controlled trials
Xi, C., Qian, D., Lu, Z., Jackson, R., Jiang, K., & Miao, Y. (2016). Effect of antecolic or retrocolic route of gastroenteric anastomosis on delayed gastric emptying after pancreaticoduodenectomy: A meta-analysis of randomized controlled trials. Pancreatology, 16(3), S62. doi:10.1016/j.pan.2016.05.211
Identification of malignant transformation within pancreatic IPMN: A systematic review and meta-analyses
Halloran, C., Jackson, R., Gilbert, T., Psarelli, E., Cox, T., Sutton, R., . . . Neoptolemos, J. (2016). Identification of malignant transformation within pancreatic IPMN: A systematic review and meta-analyses. Pancreatology, 16(3), S99. doi:10.1016/j.pan.2016.05.333
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma
Kleeff, J., Costello, E., Jackson, R., Halloran, C., Greenhalf, W., Ghaneh, P., . . . Neoptolemos, J. P. (2016). The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma. Pancreatology, 16(3), S67. doi:10.1016/j.pan.2016.05.228
Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use
Subramanian, S., Asher, R., Weston, W., Rimmer, M., McConville, A., Malin, A., . . . Rhodes, J. M. (2016). Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use. INFLAMMATORY BOWEL DISEASES, 22(8), 1902-1907. doi:10.1097/MIB.0000000000000803
Management of non metastatic castrate resistant prostate cancer (NM-CRPC), results of a UK wide national survey.
Latif, M. F., Tirmazy, S. H., Hussain, S. A., Jackson, R., Barnett, C., & Azam, F. (2016). Management of non metastatic castrate resistant prostate cancer (NM-CRPC), results of a UK wide national survey.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. doi:10.1200/JCO.2016.34.15_suppl.e16520
Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levels
Bond, A., Asher, R., Jackson, R., Sager, K., Martin, K., Kneebone, A., . . . Subramanian, S. (2016). Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levels. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 28(3), 271-276. doi:10.1097/MEG.0000000000000544
Outcome of radical cystectomy series in the management of muscle invasive bladder cancer: Liverpool experience
Hussain, S. A., Khattak, A. Q., Cornford, P., Weston, R., Somov, P., & Jackson, R. (2016). Outcome of radical cystectomy series in the management of muscle invasive bladder cancer: Liverpool experience. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. doi:10.1200/jco.2016.34.2_suppl.396
Effect of antecolic or retrocolic route of gastroenteric anastomosis on delayed gastric emptying after pancreaticoduodenectomy: A meta analysis of randomized controlled trials
Qian, D., Lu, Z., Jackson, R., Wu, J., Liu, X., Cai, B., . . . Miao, Y. (2016). Effect of antecolic or retrocolic route of gastroenteric anastomosis on delayed gastric emptying after pancreaticoduodenectomy: A meta analysis of randomized controlled trials. PANCREATOLOGY, 16(1), 142-150. doi:10.1016/j.pan.2015.11.003
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer
Takaori, K., Bassi, C., Biankin, A., Brunner, T. B., Cataldo, I., Campbell, F., . . . Johnson, C. D. (2016). International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. PANCREATOLOGY, 16(1), 14-27. doi:10.1016/j.pan.2015.10.013
2015
What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses
Sultana, A., Jackson, R., Gilbert, T., Bostock, E., Psarelli, E., Cox, T., . . . Halloran, C. (2015). What Is the Best Way to Identify MalignantTransformation Within Pancreatic IPMN: A SystematicReview and Meta-Analyses. Clinical and Translational Gastroenterology, 6(12), e130. doi:10.1038/ctg.2015.60
Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease
Poon, S. S., Asher, R., Jackson, R., Kneebone, A., Collins, P., Probert, C., . . . Subramanian, S. (2015). Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease. JOURNAL OF CROHNS & COLITIS, 9(8), 640-646. doi:10.1093/ecco-jcc/jjv084
CORRELATION OF A PATIENT REPORTED SINGLE ITEM GLOBAL DISEASE RATING SCALE TO CLINICAL AND BIOLOGICAL MARKERS OF DISEASE ACTIVITY
Rimmer, M., Asher, R., Jackson, R., Race, G., Collins, P., Dibb, M., . . . Subramanian, S. (2015). CORRELATION OF A PATIENT REPORTED SINGLE ITEM GLOBAL DISEASE RATING SCALE TO CLINICAL AND BIOLOGICAL MARKERS OF DISEASE ACTIVITY. In GUT Vol. 64 (pp. A241-A242). doi:10.1136/gutjnl-2015-309861.517
IMPACT OF BODY MASS INDEX (BMI) UPON ANTI-TNF TROUGH AND ANTI-DRUG ANTIBODY LEVELS
Bond, A., Sager, K., Phillips, S., Asher, R., Jackson, R., Kneebone, A., . . . Subramanian, S. (2015). IMPACT OF BODY MASS INDEX (BMI) UPON ANTI-TNF TROUGH AND ANTI-DRUG ANTIBODY LEVELS. In GUT Vol. 64 (pp. A91). doi:10.1136/gutjnl-2015-309861.186
Perspectives of International Association of Pancreatology (IAP)/European Pancreas Club (EPC) consensus review of guidelines for the future studies on clinical management of pancreatic cancer
Takaori, K., Bassi, C., Biankin, A., Brunner, T., Cataldo, I., Campbell, F., . . . Johnson, C. D. (2015). Perspectives of International Association of Pancreatology (IAP)/European Pancreas Club (EPC) consensus review of guidelines for the future studies on clinical management of pancreatic cancer. Pancreatology, 15(3), S113-S114. doi:10.1016/j.pan.2015.05.401
Phase II randomised placebo controlled neoadjuvant chemotherapy study of nintedanib with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer.
Hussain, S. A., Jackson, R., Shields, A., Dickinson, L., Cornford, P., Jones, R. J., . . . James, N. D. (2015). Phase II randomised placebo controlled neoadjuvant chemotherapy study of nintedanib with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 33. doi:10.1200/jco.2015.33.15_suppl.tps4574
CHEMICAL COMPATIBILITY/STABILITY OF ALFENTANIL WITH COMMONLY USED SUPPORTIVE DRUG COMBINATIONS ADMINISTERED BY CONTINUOUS SUBCUTANEOUS INFUSIONS FOR END OF LIFE CARE
Dickman, A., Roberts, E., Bickerstaff, M., Jackson, R., Weir, P., & Ellershaw, J. (2015). CHEMICAL COMPATIBILITY/STABILITY OF ALFENTANIL WITH COMMONLY USED SUPPORTIVE DRUG COMBINATIONS ADMINISTERED BY CONTINUOUS SUBCUTANEOUS INFUSIONS FOR END OF LIFE CARE. BMJ Supportive & Palliative Care, 5(1), 103.2-103. doi:10.1136/bmjspcare-2014-000838.6
The <i>Gaia</i>-ESO survey: Discovery of a spatially extended low-mass population in the Vela OB2 association
Sacco, G. G., Jeffries, R. D., Randich, S., Franciosini, E., Jackson, R. J., Cottaar, M., . . . Sbordone, L. (2015). The <i>Gaia</i>-ESO survey: Discovery of a spatially extended low-mass population in the Vela OB2 association. ASTRONOMY & ASTROPHYSICS, 574. doi:10.1051/0004-6361/201425367
Adjuvant Therapy in Pancreatic Cancer
Oldfield, F., Ghaneh, P., Jackson, R., & Halloran, C. (n.d.). Adjuvant Therapy in Pancreatic Cancer. International Journal of Digestive Diseases, 01(01). doi:10.4172/2472-1891.100003
Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.
Nicholson, J., Greenhalf, B., Jackson, R., Cox, T., Butler, J., Hanna, T., . . . Neoptolemos, J. (2015). Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.. Pancreas, 44(02), 260-265. doi:10.1097/MPA.0000000000000246
2014
Adjuvant therapy in pancreatic cancer
Jones, O. P., Melling, J. D., & Ghaneh, P. (2014). Adjuvant therapy in pancreatic cancer. WORLD JOURNAL OF GASTROENTEROLOGY, 20(40), 14733-14746. doi:10.3748/wjg.v20.i40.14733
Risk stratification, management and outcomes in emergency general surgical patients in the UK
Johnstone, M., Pennick, M., Gossedge, G., Oshin, O., Sutton, P., Dunne, D., . . . Vimalachandran, D. (2014). Risk stratification, management and outcomes in emergency general surgical patients in the UK. EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 40(5), 617-624. doi:10.1007/s00068-014-0399-2
Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancer
Sultana, A., Jackson, R. J., Cox, T., Palmer, D., Neoptolemos, J., & Ghaneh, P. (n.d.). Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancer. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011044
INCREASING WEIGHT AND BODY MASS INDEX ADVERSELY AFFECT THIOGUANINE NUCLEOTIDE LEVELS IN INFLAMMATORY BOWEL DISEASE
Subramanian, S., Poon, S., Kneebone, A., Asher, R., Jackson, R., Gregg, B., . . . Dibb, M. (2014). INCREASING WEIGHT AND BODY MASS INDEX ADVERSELY AFFECT THIOGUANINE NUCLEOTIDE LEVELS IN INFLAMMATORY BOWEL DISEASE. In GUT Vol. 63 (pp. A168). doi:10.1136/gutjnl-2014-307263.360
MEAN CORPUSCULAR VOLUME BUT NOT LYMPHOCYTE COUNT IS A PREDICTOR OF THIOPURINE DOSE ADEQUACY AND TOXICITY
Kneebone, A., Poon, S. S., Asher, R., Jackson, R., Gregg, B., Kerr, S., . . . Dibb, M. (2014). MEAN CORPUSCULAR VOLUME BUT NOT LYMPHOCYTE COUNT IS A PREDICTOR OF THIOPURINE DOSE ADEQUACY AND TOXICITY. In GUT Vol. 63 (pp. A157-A158). doi:10.1136/gutjnl-2014-307263.338
The diagnosis of chronic pancreatitis: A systematic review
Johnstone, M., Jackson, R., Hanna, T., Nicholson, J., Neoptolemos, J., Greenhalf, W., & Sutton, R. (2014). The diagnosis of chronic pancreatitis: A systematic review. Pancreatology, 14(3), S41-S42. doi:10.1016/j.pan.2014.05.520
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.
Valle, J., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., . . . Büchler, M. W. (2014). Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.. Journal of Clinical Oncology, 32(6), 504-512. doi:10.1200/JCO.2013.50.7657
A Robust Parameterization for Unbounded Covariates Within the Cox Proportional Hazards Model
Jackson, R., & Cox, T. (2014). A Robust Parameterization for Unbounded Covariates Within theCox Proportional Hazards Model. International Journal of Statistics in Medical Research, 3, 331-339. Retrieved from http://dx.doi.org/10.6000/1929-6029.2014.03.04.1
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.
Greenhalf, W., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Lamb, R. F., . . . Büchler, M. W. (2014). Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.. Journal of the National Cancer Institute, 106(1). doi:10.1093/jnci/djt347
2013
The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer
Thornton, M., Aslam, M. A., Tweedle, E. M., Ang, C., Campbell, F., Jackson, R., . . . Boyd, M. T. (2013). The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer. International Journal of Cancer, 133(6), 1408-1418. doi:10.1002/ijc.28137
The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer
Thornton, M., Aslam, M. A., Tweedle, E. M., Ang, C., Campbell, F., Jackson, R., . . . Boyd, M. T. (2013). The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer. INTERNATIONAL JOURNAL OF CANCER, 133(6), 1408-1418. doi:10.1002/ijc.28137
The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
Jackson, R., Cox, T., & Tudur-Smith, C. (2013). The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints. Trials, 14(Suppl 1), P53. doi:10.1186/1745-6215-14-s1-p53
2012
Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma
Melling, J., Thomas, A., Sykes, P., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2012). Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma. Pancreatology, 12(6), 585. doi:10.1016/j.pan.2012.11.285
Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma
Melling, J., Thomas, A., Sykes, P., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2012). Outcomes and prognostic factors following pancreaticoduodenectomy for cholangiocarcinoma. Pancreatology, 12(6), 567. doi:10.1016/j.pan.2012.11.226
Erratum: Effect of specialist decision-making on treatment strategies for colorectal liver metastases
Jones, R. P., Vauthey, J. -N., Adam, R., Rees, M., Berry, D., Jackson, R., . . . Malik, H. Z. (2012). Erratum: Effect of specialist decision-making on treatment strategies for colorectal liver metastases. British Journal of Surgery, 99(11), 1605. doi:10.1002/bjs.8969
Effect of specialist decision-making on treatment strategies for colorectal liver metastases
Jones, R. P., Vauthey, J. -N., Adam, R., Rees, M., Berry, D., Jackson, R., . . . Malik, H. Z. (2012). Effect of specialist decision-making on treatment strategies for colorectal liver metastases. BRITISH JOURNAL OF SURGERY, 99(9), 1263-1269. doi:10.1002/bjs.8835
Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of <i>TP53</i>: Final Results of the National Cancer Research Institute CLL206 Trial
Pettitt, A. R., Jackson, R., Carruthers, S., Dodd, J., Dodd, S., Oates, M., . . . Hillmen, P. (2012). Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of <i>TP53</i>: Final Results of the National Cancer Research Institute CLL206 Trial. JOURNAL OF CLINICAL ONCOLOGY, 30(14), 1647-1655. doi:10.1200/JCO.2011.35.9695
Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases
Jones, R. P., Jackson, R., Dunne, D. F. J., Malik, H. Z., Fenwick, S. W., Poston, G. J., & Ghaneh, P. (2012). Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. BRITISH JOURNAL OF SURGERY, 99(4), 477-486. doi:10.1002/bjs.8667
GRP78: a novel biomarker for benefit from fluoropyrimidine-based (5-FU) adjuvant chemotherapy in colorectal cancer and determinant of 5-FU sensitivity in colorectal cancer cells
Thornton, M., Boyd, M., Aslam, M., Tweedle, E., Ang, C., Campbell, F., . . . Rooney, P. (2012). GRP78: a novel biomarker for benefit from fluoropyrimidine-based (5-FU) adjuvant chemotherapy in colorectal cancer and determinant of 5-FU sensitivity in colorectal cancer cells. International Journal of Cancer.
2011
A robust parameterisation for the analysis of survival data in the presence of covariates with extreme value observations
Jackson, R., & Cox, T. (2011). A robust parameterisation for the analysis of survival data in the presence of covariates with extreme value observations. Trials, 12(S1). doi:10.1186/1745-6215-12-s1-a141
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: Final results of the National Cancer Research Institute (NCRI) CLL206 Trial
Pettitt, A. R., Jackson, R., Carruthers, S., Dodd, J., Dodd, S., Johnson, G. G., . . . Hillmen, P. (2011). Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: Final results of the National Cancer Research Institute (NCRI) CLL206 Trial. Journal of Clinical Oncology.
Systematic review and meta-analysis of follow up after hepatectomy for colorectal liver metastases
Jones, R. P., Dunne, D., Jackson, R., Fenwick, S., Malik, H., Poston, G., & Ghaneh, P. (2011). Systematic review and meta-analysis of follow up after hepatectomy for colorectal liver metastases. British Journal of Surgery.
2005
Adjuvant therapy of pancreatic cancer
Ghaneh, P., & Neoptolemos, J. P. (2005). Adjuvant therapy of pancreatic cancer. In E. al (Ed.), Exocrine Pancreatic Cancer. The European Pancreatic Cancer- Research Cooperative (EPC-RC) (pp. 364-381). Hannover: Felsenstein CCCP.
Undated
2-Year Neurodevelopmental Outcomes in Children Who Received Sildenafil Therapy in Utero: The STRIDER RCT
Some statistical methods for the analysis of survival data in cancer clinical trials
Jackson, R. (n.d.). Some statistical methods for the analysis of survival data in cancer clinical trials. (PhD Thesis, University of Liverpool).